Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Corominas H, Ortiz-Santamaría V, Castellví I, Moreno M, Morlà R, Clavaguera T, Erra A, Martínez-Pardo S, Ordóñez S, Santo P, Reyner P, González MJ, Codina O, Gelman MS, Juanola-Roura X, Olivé A, Torrente-Segarra V; CapiCAT group. Corominas H, et al. Among authors: clavaguera t. Rheumatol Int. 2016 Mar;36(3):365-9. doi: 10.1007/s00296-015-3396-9. Epub 2015 Nov 23. Rheumatol Int. 2016. PMID: 26597492
Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
Corominas H, Narváez J, Díaz-Torné C, Salvador G, Gomez-Caballero ME, de la Fuente D, Campoy E, Roig-Vilaseca D, Clavaguera T, Morlà R, Torrente-Segarra V, Arasa X, Gomez-Puerta JA, Möller I, Alegre C, Graell E, Ponce A, Lisbona MP, Pérez-Garcia C, Fíguls R, Sirvent E, Poca V, Sanmartí R. Corominas H, et al. Among authors: clavaguera t. Reumatol Clin. 2016 May-Jun;12(3):146-50. doi: 10.1016/j.reuma.2015.08.002. Epub 2015 Sep 8. Reumatol Clin. 2016. PMID: 26362843 Free article. English, Spanish.
VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V, Acosta Pereira A, Morla R, Ruiz JM, Clavaguera T, Figuls R, Corominas H, Geli C, Roselló R, de Agustín JJ, Alegre C, Pérez C, García A, Rodríguez de la Serna A. Torrente-Segarra V, et al. Among authors: clavaguera t. Reumatol Clin. 2016 Nov-Dec;12(6):319-322. doi: 10.1016/j.reuma.2015.11.019. Epub 2016 Jan 29. Reumatol Clin. 2016. PMID: 26831256 Free article. English, Spanish.
Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides).
Moreno M, Gratacós J, Navarro-Compán V, de Miguel E, Font P, Clavaguera T, Linares LF, Joven B, Juanola X; and the Regisponserbio group.. Moreno M, et al. Among authors: clavaguera t. Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1038-1042. Epub 2018 May 8. Clin Exp Rheumatol. 2018. PMID: 29745878 Free article.
Improved prediction of knee osteoarthritis progression by genetic polymorphisms: the Arthrotest Study.
Blanco FJ, Möller I, Romera M, Rozadilla A, Sánchez-Lázaro JA, Rodríguez A, Gálvez J, Forés J, Monfort J, Ojeda S, Moragues C, Caracuel MÁ, Clavaguera T, Valdés C, Soler JM, Orellana C, Belmonte MÁ, Martín F, Giménez S, Úcar E, Pous J, Bartolomé N, Artieda M, Szczypiorska M, Tejedor D, Martínez A, Montell E, Martínez H, Herrero M, Vergés J; Arthrotest Study Group. Blanco FJ, et al. Among authors: clavaguera t. Rheumatology (Oxford). 2015 Jul;54(7):1236-43. doi: 10.1093/rheumatology/keu478. Epub 2015 Jan 7. Rheumatology (Oxford). 2015. PMID: 25573839
18 results